Laura Lupini

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.

Oncogenic role of miR-483-3p at the IGF2/483 locus.

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.

Mutated beta-catenin evades a microRNA-dependent regulatory loop.

Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25.

BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia.

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.

Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma.

Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries.

Absolute quantification of cell-free microRNAs in cancer patients.

Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.